MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/130/0.1/20.06.25 | Market Closed - Börse Stuttgart 10:21:14 05/07/2024 pm IST | ||
| 2.52 EUR | +4.13% |
|
| Current month | -5.97% | ||
| 3 months | +36.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 2.52 | +4.13% |
| 04/24/04 | 2.42 | +5.68% |
| 03/24/03 | 2.29 | -11.58% |
| 02/24/02 | 2.59 | -7.17% |
| 01/24/01 | 2.79 | +4.10% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 10:21 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME1GBK |
| ISIN | DE000ME1GBK1 |
| Date issued | 03/10/2023 |
| Strike | 130 $ |
| Maturity | 20/06/2025 (350 Days) |
| Parity | 10 : 1 |
| Emission price | 0.62 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.88 € |
|---|---|
| Lowest since issue | 0.52 € |
| Delta | 0.71x |
| Omega | 3.614 |
| Premium | 10.92x |
| Gearing | 5.1x |
| Moneyness | 1.095 |
| Difference Strike | -12.37 $ |
| Difference Strike % | -9.52% |
| Spread | 0.01 € |
| Spread % | 0.39% |
| Theoretical value | 2.575 |
| Implied Volatility | 34.35 % |
| Total Loss Probability | 40.84 % |
| Intrinsic value | 1.141 |
| Present value | 1.434 |
| Break even | 157.91 € |
| Theta | -0.02x |
| Vega | 0.04x |
| Rho | 0.06x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974
DKK
Average target price
952.2
DKK
Spread / Average Target
-2.24%
- Stock Market
- Warrants
- Warrant
